By Research Area
Hot products 
-
Rabbit Anti-CAMK2A Recombinant Antibody (BA0032) (CBMAB-0137CQ)
-
Rat Anti-ADAM10 Recombinant Antibody (V2-179741) (CBMAB-A1103-YC)
-
Rat Anti-EPO Recombinant Antibody (16) (CBMAB-E1578-FY)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-1728) (CBMAB-2077-YY)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-GIPC2 Recombinant Antibody (10) (CBMAB-G0476-LY)
-
Mouse Anti-ADIPOR2 Recombinant Antibody (V2-179983) (CBMAB-A1369-YC)
-
Mouse Anti-BZLF1 Recombinant Antibody (BZ.1) (CBMAB-AP705LY)
-
Mouse Anti-ATP1A2 Recombinant Antibody (M7-PB-E9) (CBMAB-A4013-YC)
-
Mouse Anti-14-3-3 Pan Recombinant Antibody (V2-9272) (CBMAB-1181-LY)
-
Mouse Anti-GFAP Recombinant Antibody (20) (CBMAB-G2914-LY)
-
Rabbit Anti-DLK1 Recombinant Antibody (9D8) (CBMAB-D1061-YC)
-
Mouse Anti-dsRNA Recombinant Antibody (2) (CBMAB-D1807-YC)
-
Rabbit Anti-BAD (Phospho-Ser136) Recombinant Antibody (CAP219) (CBMAB-AP536LY)
-
Mouse Anti-dsDNA Recombinant Antibody (22) (CBMAB-AP1954LY)
-
Mouse Anti-AMIGO2 Recombinant Antibody (CBYY-C0756) (CBMAB-C2192-YY)
-
Mouse Anti-ALB Recombinant Antibody (V2-180650) (CBMAB-A2186-YC)
-
Mouse Anti-CARTPT Recombinant Antibody (113612) (CBMAB-C2450-LY)
-
Mouse Anti-GGT1 Recombinant Antibody (1F9) (CBMAB-G3273-LY)
-
Mouse Anti-CGAS Recombinant Antibody (CBFYM-0995) (CBMAB-M1146-FY)
Immunology Research
Immunology explores the molecular and cellular networks that enable organisms to distinguish self from non-self, neutralize pathogens, and maintain tissue homeostasis. The immune system comprises innate and adaptive branches, each with specialized roles. Innate immunity provides immediate, nonspecific defense via phagocytes, complement proteins, and cytokines, while adaptive immunity delivers antigen-specific responses mediated by T and B lymphocytes. Central to this duality is antigen presentation, wherein dendritic cells process and display foreign peptides to activate T cells, initiating targeted effector functions such as antibody production or cytotoxic killing.
When immune regulation fails, pathologies emerge. Autoimmune disorders arise from aberrant self-antigen recognition, as seen in rheumatoid arthritis or lupus. Allergic hypersensitivity involves excessive IgE-mediated responses to innocuous antigens, while immunodeficiencies compromise host defense, increasing susceptibility to infections. Chronic inflammation, driven by unresolved immune activation, underpins conditions like inflammatory bowel disease and atherosclerosis. Key molecular mediators—cytokines (e.g., IL-6, TNF-α), chemokines, and immune checkpoints (e.g., PD-1, CTLA-4)—orchestrate these processes, making them pivotal therapeutic targets.
Advancing immunology research hinges on dissecting signaling pathways and cellular interactions at high resolution. Technologies such as single-cell sequencing has illuminated mechanisms of immune evasion in cancer and infection. Novel modalities like monoclonal antibodies, CAR-T cells, and checkpoint inhibitors exemplify translational successes derived from foundational discoveries.
Creative Biolabs provides rigorously validated antibody reagents tailored for immunological research. Our portfolio includes antibodies targeting cytokines, immune cell markers, and signaling proteins, optimized for flow cytometry, immunohistochemistry, and functional assays. Each product undergoes stringent specificity and reproducibility testing to ensure reliability in deciphering immune mechanisms. By delivering precision tools, we empower researchers to accelerate breakthroughs in understanding and modulating immune responses.
Loading...